Biogenerics Retains Ian M. Colquhoun, Ph.D. to Spearhead Acquisition Strategy; Seasoned Industry Veteran to Lead Company's M&A Activities.

CARSON CITY, Nev. -- Biogenerics Ltd. (NQB:BIGN), focused on exploiting and distributing domestic gas reserves, today announced that the Company has retained Ian M. Colquhoun to lead its acquisition mission, extrapolating revenues and cash flows based on current assets.

Dr. Colquhoun is an exploration geologist with over seven years of experience in the Ontario oil and gas industry. He received his B.S.s. and MSc. in geology form Brock University where he published theses on the Trenton Group carbonates of southwestern Ontario. Mr. Colquhoun is also the author of several confidential reports on the Alberta oil sands pursuant to agreements between AOSTRA, the University of Western Ontario and industry. He began his career in Ontario with Pembina Resources in 1995 and has been employed as a consultant by several large and intermediate exploration companies in Ontario including; Resource Professionals Inc., Icon Petroleum Inc., Daybreak Energy Corporation, Cobra Oil and Gas Corp. and Rubicon Petroleum.

Most recently, Dr. Colquhoun served as Ontario Exploration Manager or Calgary-based Veteran Resources Inc. His background in geological consultation includes the development of exploration prospects within the Ordovician Trenton Black-River play of the Appalachian Basin and the Silurian Pinnacle Reef play of the Michigan Basin. He received a certificate of merit form the American Association of Petroleum Geologists in connection with his work on the Trenton Black-River core workshop during the Eastern Section Meeting in 2000. Dr. Colquhoun is a member of the Canadian Society of Petroleum Geologists, the AAPG, the APGO, and the Ontario Petroleum Institute.

"Dr. Colquhoun has placed the Company in a very advantageous position as his expertise and background will allow us to contemplate the most productive acquisition candidates available," stated Gary Kelley, President and CEO of Biogenerics. "Additionally, this represents another milestone in clearly positioning the company in the oil and gas industry, where the domestic need for exploration and exploitation is crucial."

Safe Harbor

The foregoing contains forward looking statements. For this purpose any statements contained in this document that are not statements of historical fact may be deemed to be forward looking statements. Without limiting the foregoing, such words a "may", "will", "believes", "estimates", "continue", or comparable terminology intends to identify forward looking statements. These statements by their nature involve substantial risks and uncertainties and actual results may differ materially depending upon a variety of factors stated in the Company's filings with the Securities and Exchange Commission.